Zurich Cantonal Bank
PHAT icon

Zurich Cantonal Bank’s Phathom Pharmaceuticals PHAT Stock Holding History

Zurich Cantonal Bank’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,890
Closed -$330K – 3257
2025
Q4 		$330K Buy
+19,890
New +$284K ﹤0.01% 2004

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Zurich Cantonal Bank's PHAT Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Phathom Pharmaceuticals (PHAT) in Q1 2026: 24,992 shares worth $278K. The stake represents ﹤0.01% of the portfolio and ranks #2133 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in PHAT as recently as Q1 2025.

Zurich Cantonal Bank first reported a position in PHAT in Q1 2023 and has held it in 10 quarters since. 174 funds tracked by Wall St. Rank hold PHAT as of Q1 2026.

  • Zurich Cantonal Bank held 24,992 shares of Phathom Pharmaceuticals worth $278K as of Q1 2026.
  • Phathom Pharmaceuticals was a new Zurich Cantonal Bank position in Q1 2026.
  • Phathom Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #2133 holding.
  • Zurich Cantonal Bank first reported a position in Phathom Pharmaceuticals in Q1 2023 and has held it in 10 quarters since.
  • 174 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.